Retained Earnings (Accumulated Deficit) of HERON THERAPEUTICS, INC. /DE/ from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
HERON THERAPEUTICS, INC. /DE/ quarterly Retained Earnings (Accumulated Deficit) in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • HERON THERAPEUTICS, INC. /DE/ Retained Earnings (Accumulated Deficit) for the quarter ending 31 Dec 2025 was $1,939,789,000, a 1.1% decline year-over-year.
Source SEC data
View on sec.gov
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

HERON THERAPEUTICS, INC. /DE/ Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,939,789,000 -$20,195,000 -1.1% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $1,936,835,000 -$13,578,000 -0.71% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $1,919,340,000 -$931,000 -0.05% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $1,916,959,000 -$7,785,000 -0.41% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $1,919,594,000 -$13,580,000 -0.71% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $1,923,257,000 -$27,967,000 -1.5% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $1,918,409,000 -$48,127,000 -2.6% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $1,909,174,000 -$80,951,000 -4.4% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $1,906,014,000 -$110,559,000 -6.2% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $1,895,290,000 -$119,704,000 -6.7% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $1,870,282,000 -$136,604,000 -7.9% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $1,828,223,000 -$150,904,000 -9% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $1,795,455,000 -$182,024,000 -11% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 $1,775,586,000 -$216,801,000 -14% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $1,733,678,000 -$227,301,000 -15% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $1,677,319,000 -$231,957,000 -16% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $1,613,431,000 -$220,683,000 -16% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $1,558,785,000 -$228,318,000 -17% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $1,506,377,000 -$234,138,000 -18% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $1,445,362,000 -$228,313,000 -19% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $1,392,748,000 -$227,278,000 -20% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $1,330,467,000 -$222,917,000 -20% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $1,272,239,000 -$198,284,000 -18% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $1,217,049,000 -$193,316,000 -19% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $1,165,470,000 -$204,749,000 -21% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q3 2019 $1,107,550,000 -$196,388,000 -22% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $1,073,955,000 -$201,139,000 -23% 30 Jun 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 $1,023,733,000 -$189,586,000 -23% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $960,721,000 -$177,266,000 -23% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 $911,162,000 -$190,197,000 -26% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 $872,816,000 -$193,717,000 -29% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 $834,147,000 -$197,847,000 -31% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 $783,455,000 -$197,484,000 -34% 31 Dec 2017 10-K 02 Mar 2020 2019 FY
Q3 2017 $720,965,000 -$182,957,000 -34% 30 Sep 2017 10-Q 06 Nov 2017 2017 Q3
Q2 2017 $679,099,000 -$189,600,000 -39% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 $636,300,000 -$190,027,000 -43% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 $585,971,000 -$173,143,000 -42% 31 Dec 2016 10-K 27 Feb 2018 2017 FY
Q3 2016 $538,008,000 -$156,422,000 -41% 30 Sep 2016 10-Q 08 Nov 2016 2016 Q3
Q2 2016 $489,499,000 -$130,585,000 -36% 30 Jun 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 $446,273,000 -$110,466,000 -33% 31 Mar 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 $412,828,000 -$97,591,000 -31% 31 Dec 2015 10-K 23 Feb 2017 2016 FY
Q3 2015 $381,586,000 -$86,973,000 -30% 30 Sep 2015 10-Q 06 Nov 2015 2015 Q3
Q2 2015 $358,914,000 -$83,495,000 -30% 30 Jun 2015 10-Q 07 Aug 2015 2015 Q2
Q1 2015 $335,807,000 -$79,399,000 -31% 31 Mar 2015 10-Q 08 May 2015 2015 Q1
Q4 2014 $315,237,000 -$76,367,000 -32% 31 Dec 2014 10-K 19 Feb 2016 2015 FY
Q3 2014 $294,613,000 -$69,786,000 -31% 30 Sep 2014 10-Q 06 Nov 2014 2014 Q3
Q2 2014 $275,419,000 -$63,465,000 -30% 30 Jun 2014 10-Q 04 Aug 2014 2014 Q2
Q1 2014 $256,408,000 -$59,868,000 -30% 31 Mar 2014 10-Q 12 May 2014 2014 Q1
Q4 2013 $238,870,000 -$55,283,000 -30% 31 Dec 2013 10-K 13 Mar 2015 2014 FY
Q3 2013 $224,827,000 -$48,977,000 -28% 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 $211,954,000 -$42,225,000 -25% 30 Jun 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 $196,540,000 -$31,380,000 -19% 31 Mar 2013 10-Q 10 May 2013 2013 Q1
Q4 2012 $183,587,000 -$23,348,000 -15% 31 Dec 2012 10-K 07 Mar 2014 2013 FY
Q3 2012 $175,850,000 -$19,872,000 -13% 30 Sep 2012 10-Q 05 Nov 2012 2012 Q3
Q2 2012 $169,729,000 -$17,953,000 -12% 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 $165,160,000 31 Mar 2012 10-Q 10 May 2012 2012 Q1
Q4 2011 $160,239,000 -$11,814,000 -8% 31 Dec 2011 10-K 01 Mar 2013 2012 FY
Q3 2011 $155,978,000 30 Sep 2011 10-Q 07 Nov 2011 2011 Q3
Q2 2011 $151,776,000 30 Jun 2011 10-Q 08 Aug 2011 2011 Q2
Q4 2010 $148,425,000 31 Dec 2010 10-K 26 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.